PARADIGM BIOCAPITAL ADVISORS LP 13F Portfolio
PARADIGM BIOCAPITAL ADVISORS LP runs PARADIGM BIOCAPITAL ADVISORS LP and currently holds 28 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $5.34B. Their top holdings are RVMD, NUVL, EWTX, GMAB, SYRE. The top five represent 56.9% of reported portfolio weight. PARADIGM BIOCAPITAL ADVISORS LP ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, PARADIGM BIOCAPITAL ADVISORS LP initiated 5 new positions. They added to 10 existing positions. They trimmed 6 positions. Their current best-performing preview position is ORKA with returns of +94.03%.
Portfolio Value
$5.34B
Alpha Score
131.1
#0 of 1000
Holdings
28
PARADIGM BIOCAPITAL ADVISORS LP Current 13F Holdings
Reported holdings from PARADIGM BIOCAPITAL ADVISORS LP's latest SEC 13F filing, ranked by portfolio weight.
28 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 RVMD REVOLUTION MEDICINES INC | 22.31% | $39.65 | $189.76 | +378.59% | Trimmed -4.42% |
 NUVL NUVALENT INC | 13.70% | $73.34 | $123.96 | +69.02% | Added +11.27% |
 EWTX EDGEWISE THERAPEUTICS INC | 7.77% | $26.62 | $39.06 | +46.73% | Added +38.70% |
 GMAB GENMAB A/S | 6.76% | $29.17 | $37.07 | +27.08% | Added +64.83% |
 SYRE SPYRE THERAPEUTICS INC | 6.38% | $59.49 | $85.69 | +44.04% | Added +96.23% |
 APGE APOGEE THERAPEUTICS INC | 3.92% | $66.06 | $135.07 | +104.47% | Added +16.92% |
 ORKA ORUKA THERAPEUTICS INC | 3.82% | $35.24 | $82.11 | +133.00% | Trimmed -7.58% |
 TNGX TANGO THERAPEUTICS INC | 3.72% | $24.74 | $23.81 | -3.76% | Added +58.55% |
 ERAS ERASCA INC | 3.28% | $2.44 | $16.03 | +556.97% | Trimmed -8.11% |
 TARS TARSUS PHARMACEUTICALS INC | 3.27% | $35.17 | $73.16 | +108.02% | Added +8.33% |
Showing 1-10 of 28